HDM-2005

N/A

Report date: 2026/01/15 16:19:51

Base Information

Drug NameHDM-2005
Drug Alias NameHDM2005HDM-2005
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-Inactive tyrosine-protein kinase transmembrane receptor ROR1Tubulin polymerisation inhibitors
TargetsInactive tyrosine-protein kinase transmembrane receptor ROR1Tubulin
Therapy Area/IndicationsSolid tumoursHematologic NeoplasmsLymphoma, Mantle-Cell +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesHangzhou Zhongmei Huadong Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesHangzhou Zhongmei Huadong Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic NeoplasmsLymphoma, Mantle-Cell +[5] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A